FGFR4 — Drug Target

All drugs that target FGFR4 — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

FGFR4 kinase inhibitor · antisense oligonucleotide · FGFR4 inhibitor

Phase 3 pipeline (1)

• BAY3723113 · Bayer · FGFR4 kinase inhibitor · Oncology
  BAY3723113 is a selective inhibitor of fibroblast growth factor receptor 4 (FGFR4) that blocks aberrant FGF/FGFR signaling in hepatocellular carcinoma and other cancers.

Phase 2 pipeline (2)

• ISIS-FGFR4RX · Ionis Pharmaceuticals, Inc. · antisense oligonucleotide · Oncology
  Antisense oligonucleotide targeting fibroblast growth factor receptor 4
• AZD5004 · AstraZeneca · FGFR4 inhibitor · Oncology
  AZD5004 is a selective inhibitor of fibroblast growth factor receptor 4 (FGFR4) that blocks aberrant FGF signaling in hepatocellular carcinoma and other cancers.